Bank Of America Corp Arbutus Biopharma Corp Call Options Transaction History

Bank Of America Corp

  • $1.19 Trillion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Feb 08, 2022
SELL
$3.11 - $4.61 $2.23 Million - $3.31 Million
-717,200 Reduced 58.69%
504,800 $1.96 Million
Q3 2021

Nov 15, 2021
BUY
$2.65 - $4.62 $3.01 Million - $5.24 Million
1,134,000 Added 1288.64%
1,222,000 $5.24 Million
Q2 2021

Sep 13, 2021
BUY
$2.5 - $3.51 $220,000 - $308,880
88,000 New
88,000 $267,000

Others Institutions Holding ABUS

# of Institutions
155
Shares Held
99.5M
Call Options Held
2.31M
Put Options Held
525K
View Full List

About Arbutus Biopharma Corp

ABUS Quotes by TradingView
  • Ticker ABUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 149,951,008
  • Market Cap $478M
  • Description
  • Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...
More about ABUS
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email